| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 28.238 | 61.211 | 169.637 | 0 | 4.505 | 12.907 | 27.642 | 30.570 | 22.374 | 26.490 |
| Total Income - EUR | 30.483 | 70.825 | 196.832 | 0 | 4.505 | 13.091 | 29.383 | 31.357 | 22.374 | 26.490 |
| Total Expenses - EUR | 27.182 | 71.695 | 171.815 | 12.085 | 40.911 | 59.597 | 29.725 | 33.542 | 30.765 | 30.263 |
| Gross Profit/Loss - EUR | 3.301 | -869 | 25.017 | -12.085 | -36.406 | -46.506 | -342 | -2.185 | -8.390 | -3.773 |
| Net Profit/Loss - EUR | 2.387 | -1.761 | 22.609 | -12.085 | -36.540 | -46.883 | -1.224 | -3.125 | -8.390 | -3.773 |
| Employees | 1 | 3 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Naturaland Pharm Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 124 | 4.223 | 32.066 | 261.919 | 290.594 | 300.452 | 273.046 | 252.974 | 233.702 | 217.241 |
| Current Assets | 11.599 | 54.043 | 2.945 | 7.368 | 79.111 | 17.643 | 18.996 | 19.164 | 22.503 | 22.088 |
| Inventories | 6.309 | 34.193 | -3.005 | 0 | 18.628 | 0 | 849 | 0 | 0 | 0 |
| Receivables | 2.688 | 15.253 | 4.476 | 7.360 | 35.281 | 17.540 | 17.782 | 18.516 | 22.161 | 19.619 |
| Cash | 2.602 | 4.597 | 1.475 | 8 | 25.202 | 103 | 364 | 648 | 342 | 2.469 |
| Shareholders Funds | -8.328 | -9.967 | 10.971 | -1.315 | -37.830 | -83.996 | -83.357 | -86.741 | -94.868 | -98.110 |
| Social Capital | 45 | 82 | 81 | 80 | 78 | 76 | 75 | 75 | 75 | 74 |
| Debts | 20.052 | 68.232 | 24.040 | 270.602 | 407.534 | 402.090 | 375.398 | 358.879 | 351.072 | 337.439 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8299 - 8299" | |||||||||
| CAEN Financial Year |
6820
|
|||||||||
Comments - Naturaland Pharm Srl